CD83 and neoplasm: The analysis of memory T cells at day 59 in an independent experiment revealed that most of the M2 specific T cells were effector memory (CD83+CD8+IFNγ+CD44+CD62LLO), thus suggesting that a boost in the immune response could further improve tumor protection (Additional file 2: Figure S4).